✦ LIBER ✦

Multicenter Randomized Phase II Clinical Trial of a Recombinant Human Endostatin Adenovirus in Patients with Advanced Head and Neck Carcinoma

✍ Scribed by Ye, Wen; Liu, Ranyi; Pan, Changchuan; Jiang, Wenqi; Zhang, Li; Guan, Zhongzhen; Wu, Jiangxue; Ying, Xiaofang; Li, Lixia; Li, Su; Tan, Wen; Zeng, Musheng; Kang, Tiebang; Liu, Qing; Thomas, George R.; Huang, Manli; Deng, Wuguo; Huang, Wenlin

Book ID: 127217496
Publisher: Nature Publishing Group
Year: 2014
Tongue: English
Weight: 909 KB
Volume: 22
Category: Article
ISSN: 1525-0016
DOI: 10.1038/mt.2014.53

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter phase II trial of brequinar

Multicenter phase II trial of brequinar sodium in patients with advanced squamous-cell carcinoma of the head and neck

✍ Susan Urba; James Doroshow; Christine Cripps; Francisco Robert; Enrique Velez-Ga 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 260 KB

A phase II trial of recombinant tumor ne

A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma

✍ Nancy Kemeny; Barry Childs; William Larchian; Kim Rosado; David Kelsen 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

A phase II study of pirarubicin in patie

A phase II study of pirarubicin in patients with advanced recurrent head and neck squamous cell carcinoma

✍ P. H. M. De Mulder, P. Cappelaere, F. Cognetti… 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 296 KB

A phase II study of piritrexim in patien

A phase II study of piritrexim in patients with advanced squamous cell carcinoma of the head and neck

✍ Degardin, M.; Domenge, C.; Cappelaere, P.; Luboinski, B.; Navarrete, M.S.; Scott 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Phase III Randomized Trial of Induction

Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer

✍ Cohen, E. E. W.; Karrison, T. G.; Kocherginsky, M.; Mueller, J.; Egan, R.; Huang 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 272 KB

A randomized multicenter phase II clinic

A randomized multicenter phase II clinical trial of mitoxantrone-loaded nanoparticles in the treatment of 108 patients with unresected hepatocellular carcinoma

✍ Qinghua Zhou; Xun Sun; Lingyuan Zeng; Jie Liu; Zhirong Zhang 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 151 KB

## From the clinical editor: Intravenous administration of mitoxantrone-loaded polybutylcyanacrylate nanoparticles (dhad-pbca-nps) allows increased cytotoxicity in hepatic tumors and prolonged the median survival periods to 5.46 months compared to 3.23 months in controls.